glp-1 pathophysiology Mechanism of action of [25] The Physiology of Glucagon-like Peptide

If these findings translate clinically, targeting #TXNIP could represent a fundamentally new approach to weight maintenance after #weightloss therapy, an area where there are currently few options

If you want to add something else, add one thing at a time

It demonstrated a 14% reduction in major cardiovascular events and a 26% reduction in heart attacks specifically for Asian patients.[19] The kidney story gained momentum with the FLOW trial, the first dedicated kidney outcomes study of a GLP-1 medicine

Unlike FDA-approved medications, compounded drugs are not reviewed by the Food and Drug Administration for safety, quality, or effectiveness before they are marketed

Do not take two doses at the same time to catch up

Aug 2013;21(8):1602-7